Sökning: "Therapy resistance"
Visar resultat 16 - 20 av 436 avhandlingar innehållade orden Therapy resistance.
16. Study of Resistance in Hepatitis C Virus Prior to Treatment with Direct Acting Antivirals
Sammanfattning : The rapid advancement of Hepatitis C (HCV) treatment presents a great challenge to clinicians in optimising therapy for their patients. Genotype (GT), efficacy, side-effects, drug combinations and treatment durations must be tailored to individual patients, considering comorbidities, degree of fibrosis, adherence and antiviral resistance. LÄS MER
17. Women's hearts : ischaemic heart disease and stress management in women
Sammanfattning : Acute myocardial infarction (AMI), caused by ischaemic heart disease (IHD), is a leading cause of death in both men and women in the western society. Hypertension, diabetes, and smoking are examples of well-known risk factors of IHD, but also there are psychosocial factors, such as stress, vital exhaustion (unusual fatigue, irritability, and demoralization) and depression that have been associated with an increased risk in both genders. LÄS MER
18. Glucocorticosteroid therapy and steroid resistance in inflammatory bowel disease
Sammanfattning : Ulcerative colitis (UC) and Crohn's disease (CD) are diseases of unknown aetiology often referred to as inflammatory bowel diseases (IBD). Glucocorticosteroids (GCS) have been used since the 1950's to treat acute attacks of these diseases. LÄS MER
19. Unravelling molecular mechanisms underlying therapy resistance in cutaneous melanoma
Sammanfattning : For many years the standard treatment of advanced metastatic melanoma with chemotherapeutic agents, including temozolomide (TMZ) and dacarbazine (DTIC), has been unsuccessful. The paradigm shift in melanoma treatment occurred with the identification of mutations in the BRAF gene that leads to a constitutively active BRAF V600E protein. LÄS MER
20. Modelling the evolution of treatment-induced resistance in Ph+ leukaemias
Sammanfattning : Targeted therapies are a mainstay of modern cancer treatments. Rather than harming rapidly dividing cells in general, targeted therapies work by directly interfering with oncogenic molecular pathways present in a tumour. Consequently, a targeted therapy typically has less severe side effects. LÄS MER